drugset / Trial / NCT00011895

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00011895

Phase 4 Unknown 400 enrolled GlaxoSmithKline
Treatment

Summary

The purpose of this study is to determine the effect of treatment with Trizivir (TZV) plus efavirenz (EFV) or TZV alone on viral load (level of HIV in the blood).

Timeline

Start
2001-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Abacavir Other / unclassified
Subject Efavirenz Other / unclassified
Subject Lamivudine Other / unclassified
Subject Zidovudine Small molecule